4.3 Article

Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Targeting Insulin-Degrading Enzyme in Insulin Clearance

Malcolm A. Leissring et al.

Summary: Hepatic insulin clearance and the activity of insulin-degrading enzyme might be involved in the pathogenesis of type 2 diabetes mellitus, and the development of IDE inhibitors as therapeutics for diabetic patients has garnered attention.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Endocrinology & Metabolism

Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans

Andin Fosam et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients

A. D. Genazzani et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy

Seema Patel

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)

Review Endocrinology & Metabolism

Polycystic ovary syndrome and nonalcoholic fatty liver disease

Djuro Macut et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)

Article Obstetrics & Gynecology

Inositol as putative integrative treatment for PCOS

Alessandro D. Genazzani

REPRODUCTIVE BIOMEDICINE ONLINE (2016)

Article Endocrinology & Metabolism

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Gerard Conway et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)

Article Endocrinology & Metabolism

Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients

Alessandro D. Genazzani et al.

GYNECOLOGICAL ENDOCRINOLOGY (2014)

Article Endocrinology & Metabolism

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione

Michael W. O'Reilly et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Review Pharmacology & Pharmacy

The Rationale of the Myo-Inositol and D-Chiro-Inositol Combined Treatment for Polycystic Ovary Syndrome

Simona Dinicola et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2014)

Article Endocrinology & Metabolism

Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals

Francis M. Finucane et al.

DIABETOLOGY & METABOLIC SYNDROME (2014)

Article Endocrinology & Metabolism

Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients

Alessandro D. Genazzani et al.

GYNECOLOGICAL ENDOCRINOLOGY (2012)

Article Endocrinology & Metabolism

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials

V. Unfer et al.

GYNECOLOGICAL ENDOCRINOLOGY (2012)

Review Endocrinology & Metabolism

First-phase insulin secretion: does it exist in real life? Considerations on shape and function

A Caumo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)

Article Endocrinology & Metabolism

The prevalence and features of the polycystic ovary syndrome in an unselected population

R Azziz et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Article Endocrinology & Metabolism

Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT

A Tura et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)